Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tetomilast in COPD with Emphysema
NCT00874497Phase 2Terminated
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization
- Start
- Mar 2009
- Primary completion
- Jul 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of tetomilast in chronic obstructive pulmonary disease (COPD), emphysema, sponsored by Otsuka Pharmaceutical Development & Commercialization. Started Mar 2009; status: terminated.
02
Drugs
tetomilast
03
Conditions
chronic obstructive pulmonary disease (COPD)emphysema
Beyond the preview
Go deeper on NCT00874497.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00874497.